MRKR: Marker Therapeutics Inc
MRKR exchange rate has changed by -0.72% for today. During the day, the instrument was traded at a low of 1.33 and at a high of 1.41.
Follow Marker Therapeutics Inc dynamics. Real-time quotes will help you quickly react to market changes. By switching between different timeframes, you can monitor exchange rate trends and dynamics by minutes, hours, days, weeks, and months. Use this information to forecast market changes and to make informed trading decisions.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
MRKR News
- Profound Medical (PROF) Reports Q4 Loss, Misses Revenue Estimates
- Marker Therapeutics sets date for 2026 annual shareholder meeting and proposal deadline
- MRKR Stock Up Nearly 114% in 3 Months: Here's What You Need to Know
- Zacks Industry Outlook Highlights Soleno Therapeutics, Nektar Therapeutics, Rigel Pharmaceuticals, Ironwood Pharmaceuticals and Marker Therapeutics
- MARKER THERAPEUTICS, INC. (MRKR) Now Trades Above Golden Cross: Time to Buy?
- 5 Small Drug Stocks to Buy as Industry Recovery Picks Up
- Marker Therapeutics stock maintains Buy rating at H.C. Wainwright
- Brookline Capital raises Marker Therapeutics stock price target to $5.60
- H.C. Wainwright reiterates Buy rating on Marker Therapeutics stock
- Marker Therapeutics appoints Kathryn Penkus Corzo to board of directors
- Marker Therapeutics Stock Drops After Report About Lymphoma Treatment - Marker Therapeutics (NASDAQ:MRKR)
- Marker’s lymphoma therapy shows promising response rates in trial
- Dow Jumps Over 100 Points; PepsiCo Posts Upbeat Earnings - GameSquare Holdings (NASDAQ:GAME), CareDx (NASDAQ:CDNA)
- Marker Therapeutics and Cellipont Bioservices Announce Collaboration to Advance cGMP Manufacturing of MT-601, a Multi-Antigen Recognizing T Cell Therapy for Patients with Lymphoma
- Marker Therapeutics to Spotlight Multi-Antigen Recognizing (MAR)-T Cells in High-Profile Panel on CAR-T Cell Therapies
Frequently Asked Questions
What is MRKR stock price today?
Marker Therapeutics Inc stock is priced at 1.38 today. It trades within 1.33 - 1.41, yesterday's close was 1.39, and trading volume reached 62. The live price chart of MRKR shows these updates.
Does Marker Therapeutics Inc stock pay dividends?
Marker Therapeutics Inc is currently valued at 1.38. Dividend policy depends on the company, while investors also watch 18.97% and USD. View the chart live to track MRKR movements.
How to buy MRKR stock?
You can buy Marker Therapeutics Inc shares at the current price of 1.38. Orders are usually placed near 1.38 or 1.68, while 62 and 0.73% show market activity. Follow MRKR updates on the live chart today.
How to invest into MRKR stock?
Investing in Marker Therapeutics Inc involves considering the yearly range 0.81 - 4.07 and current price 1.38. Many compare -6.12% and 56.82% before placing orders at 1.38 or 1.68. Explore the MRKR price chart live with daily changes.
What are Marker Therapeutics Inc stock highest prices?
The highest price of Marker Therapeutics Inc in the past year was 4.07. Within 0.81 - 4.07, the stock fluctuated notably, and comparing with 1.39 helps spot resistance levels. Track Marker Therapeutics Inc performance using the live chart.
What are Marker Therapeutics Inc stock lowest prices?
The lowest price of Marker Therapeutics Inc (MRKR) over the year was 0.81. Comparing it with the current 1.38 and 0.81 - 4.07 shows potential long-term entry points. Watch MRKR moves on the chart live for more details.
When did MRKR stock split?
Marker Therapeutics Inc has gone through stock splits historically. These changes are visible in , 1.39, and 18.97% after corporate actions.
- Previous Close
- 1.39
- Open
- 1.37
- Bid
- 1.38
- Ask
- 1.68
- Low
- 1.33
- High
- 1.41
- Volume
- 62
- Daily Change
- -0.72%
- Month Change
- -6.12%
- 6 Months Change
- 56.82%
- Year Change
- 18.97%